November 7, 2017
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re:AntriaBio, Inc. (the "Company")
Registration Statement on Form S-1
File No. 333-220585

Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 PM EST on November 8, 2017 or as soon thereafter as is practicable.

Very truly yours,
By: /s/ Nevan Elam                     
Name:  Nevan Elam
Title:    Chief Executive Officer